Firdapse for LEMS in Adults
Firdapse (amifampridine, Catalyst Pharmaceuticals)
Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
Dosage: 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily); increased by 5mg daily every 3-4 days, not to exceed 80mg daily
Contraindications: History of seizures; hypersensitivity to amifampridine or another aminopyridine
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
